Systems and methods for enhanced diagnosis of transthyretin cardiac amyloidosis
AssigneeMayo Foundation for Medical Education and Research
InventorsIshan Garg, Andrew C. Hoffman, Geoffrey B. Johnson
Life of this patent
Estimating the term…
Loading patent…
AssigneeMayo Foundation for Medical Education and Research
InventorsIshan Garg, Andrew C. Hoffman, Geoffrey B. Johnson
Estimating the term…
Systems and methods for enhanced diagnosis of transthyretin-related cardiac amyloidosis in a subject are disclosed. The systems and methods may use both SPECT imaging data as well as an anatomical imaging data, such as computed tomography (CT) data, to produce a combined image. Within the combined image, the radiotracer uptake between two volumes of interests are compared, one of which may represent the left ventricle of the subject and the other may represent the blood pool retention of the subject. Combining the anatomical imaging data with SPECT data enables better anatomical delineation and helps in avoiding areas with coronary or lymph node calcifications and overlying soft tissue and bony pathologies.
A method for diagnosing transthyretin cardiac amyloidosis in a subject, the method comprising:
A method for diagnosing transthyretin cardiac amyloidosis in a subject, the method comprising:
A system for diagnosing transthyretin cardiac amyloidosis in a subject, the system comprising:
Dependencies are inferred from the claim text.